A6MVX2 AF NFT

DNA-directed RNA polymerase subunit beta''

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeib7q5jojc4xhnjoujxkcinalwbrpukxledmtabrr45njp57vd5ote/metadata.json
IPFS of structure file: 
bafybeihhju74h4amvwgqabb2pqukc7f7pdjvxrqvcxwoy4fkrzka7fr4mu/AF-A6MVX2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xC24809Abb479FF4227EFEceC2ca4E7f8FBA2E683
First NFT owner address (bech32): 
genesis1cfyqn2a508l5yfl0ankzef88lra69e5rqg7rg2
Current NFT ID #388105 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
388105
Accession (UniProt):
A6MVX2
Name::
DNA-directed RNA polymerase subunit beta''
Experimental Method:
Predicted structure
Sequence source:
Rhodomonas salina

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A6MVX2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A6MVX2|RPOC2_RHDSA DNA-directed RNA polymerase subunit beta'' OS=Rhodomonas salina OX=52970 GN=rpoC2 PE=3 SV=1 MKEKYLFIPPKPKFTNKTIDKKELKKLMAWAFSNYGTGRASYLADKIKDLGFQYATKAGLSLSVEDLRVPPTKRELLKRTNEEINLTQQKYERGEITTVERFQKVIDTWNNASEELKDEVVKYFKETDPLNTIYIMAFSGARGNISQVRQLVGMRGLMADPQGQIIDLPIKSNFREGLTVTDYIISSYGARKGLVDTALRTADSGYLTRRLVDVAQDIIIREIDCDTDRGILLKDMVSNNQILIPLQNRLLGRVLFETLHSPDSANVIAHINQDLDHNTAEFIVKSGIKSVIVRSPLTCESSRSVCQFCYGWNLAHGSLVDLGEAVGIIAAQSIGEPGTQLTMRTFHTGGVFTGELAEQIRAPFDGVLRIPKSFRTRLIRTRHGEEAFVLEDSYKLDLYDSSYKKHKIEFKQGTILFLNDNEQFKKSQVIGELSTKSSMITERVTKDLNTENSGEVCFSNLYIEEKIDRQGNSITNTPKGGCLWILSGEVYNLPSYADIKIKEKQFVEEDEVLATSKVISDYGGLVRLNQSNQTSNITELQIVTSSVSLDNATIVTDDQKSTNSDPSYTLEMECGIKFHMLCSPGNKIVNSQIIAELIDTKYQTSTGGIVKYDGFEVNKKNKNKKGYEILGEGALLWIPEETHEINKDISLLLVEEGQCITAGTQIVKELYSLTEGYIQIIQENEIVKEVIVKPGKEHVRSTTSNNLNEYPKIVKPNDPDYAEYNAQGTIYIEELHYKKGNALLIRPVIEFRIDNEKIDLKTNYLTNENHHITIKPTKRVLFKDGQRVKSKYGVDLLKTYLIMSVDFDKPHLSADVEFVPAHEDDIYKLHLTVLETLQIKQDDFGESKKKSTITSLCVKQNELIKAGSTVAETHLLAHSAGFVQSINQTSQSTCKVLILTNSDEKSIDIYNQTPQVSQGDFIRSGDQIANGIIAETSGQIVEIETNKIKIRSGTPYLVSSNAILQVKNGNLVETGDTLAILVFERSKTGDIVQGLPRIEEILEARKPKEPSKLSQRPGKITLNYDSEDNKCIRILSSNGEYNEYIMSGIQKIIVSNGENILLAEPITDGAPNPHEMLGLFFNFYKERMPLYEAAKLALQKVQIYLVNEVQNVYQSQNVDISDKHIEVIVRQMTSKVKVEDGGDTTLLPGELVELQQIENINEAMTLTKGLPARYSPVLLGITKSSLNTDSFISAASFQETTRVLTEAAIEGKADWLRGLKENVIIGRLIPAGTGFNSYNDISKSFVLEKKNQMPDSYEQNQNEEQNIEDIILDDNIARNYALIENPINNFDTIEQNINQSKDI